Menu
02b-653x337_toraymixin_eaa

Sepsis and septic shock

TORAYMYXIN®

State-of-the-art therapy for patients with endotoxic septic shock

Septic shock is associated with an unacceptable high mortality and a significant economic burden to the sanitary system. Endotoxin is the most potent trigger of the septic cascade and during the progress of sepsis, endotoxin levels can increase up to 1000 fold, even when cultures result negative for Gram-negative bacteria.

Toraymyxin®  Polymyxin B hemoperfusion therapy – from Toray Medical Ltd. (Japan), is the state-of-the-art therapy for endotoxin removal in septic shock patients. More than 150,000 patients have been treated with this innovative therapy and more than 250 peer-reviewed articles have been published, demonstrating the beneficial effects on hemodynamics, organ function and mortality.

EAA™Endotoxin Activity Assay – is the only FDA approved diagnostic assay to detect endotoxin activity in human whole blood. The EAA™ diagnostic test is performed in less than 30 minutes. EAA™ is the diagnostic assay to identify patients with endotoxic septic shock.

chronic-kidney-disease-653x337

Chronic kidney disease

Filtryzer® PMMA

A personalized therapy based on the individual needs of each patient

acute-respiratory-failure-653x337

Acute respiratory failure

ProLUNG®

A minimally invasive extracorporeal CO2 removal system for ventilatory support

Focus on

WKD-2019-653x337px

WORLD KIDNEY DAY – MARCH 14, 2019

World Kidney Day is a global initiative aimed at raising awareness of the importance of our kidneys. The campaign sets out to raise awareness of the high and increasing burden of kidney disease worldwide and of the need for strategies for kidney disease prevention and management.

ISICEM-2019-653x337px

ISICEM 2019 – BRUSSELS

Estor is present at the 39th International Symposium on Intensive Care and Emergency Medicine (ISICEM), March 19-22, 2019, Brussels, Belgium.
Come and meet us at our booth #1.56

SRLF_PARIS_2018-653x337px

RÉANIMATION 2019 – PARIS

The Réanimation 2019 meeting organized by SRLF (Société de Réanimation de Langue Française) takes place from January 23-25, 2019, at Porte de Versailles in Paris, France.

We are present with Exposition Area (booth #91)

On January 24 we support the Atelier: Thérapie additionnelle dans le choc septique endotoxinique : la thérapie de Polymyxine B en hémoperfusion.

Come and visit us!